Skip to main contentSkip to navigation
Sirius Investors

LPCUF Stock: Lee's Pharmaceutical Holdings Limited Stock Price, Analysis & Insights

Get live LPCUF stock price $0.19, comprehensive Lee's Pharmaceutical Holdings Limited stock analysis, charts, news, and expert forecast. Real-time LPCUF stock data and investment insights.

0.19
0.00%Today
LPCUFLee's Pharmaceutical Holdings Limited • Other OTC • Healthcare
Market Cap
112.06M
Volume
6.00K
52W High
0.20
52W Low
0.19

Loading chart data...

Lee's Pharmaceutical Holdings Limited (LPCUF) Overview

Lee's Pharmaceutical Holdings Limited (LPCUF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, LPCUF trades at $0.19 with a market capitalization of 112.06M . Over the past 52 weeks, LPCUF has traded between $0.19 and $0.20 , with the current price positioned at approximately 18%...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 112.06M
  • Current price: $0.19
  • 52-week range: $0.19 - $0.20
  • P/E ratio: 9.51

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Lee's Pharmaceutical Holdings Limited functions as an investment holding company primarily focused on the development, manufacturing, and commercialization of pharmaceutical products within the People's Republic of China. The company's therapeutic sc...

Company Information

CEO
Siu Fong Lee
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1022

Contact Information

Address
Building 20E
Country
HK

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 9.5)

Lower volatility stock (Beta: 0.56) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Lee's Pharmaceutical Holdings Limited shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Lee's Pharmaceutical Holdings Limited
  • Investors should consider how Lee's Pharmaceutical Holdings Limited fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

112.06M

P/E Ratio (TTM)

9.51

Beta

0.56

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.